BMO Capital analyst Keith Bachman raised his price target for Accenture to $195 from $185 saying the company had a "net positive quarter," with continued strength in revenues but weak signings. The latter is largely due to timing rather than demand issues in the pipeline, however, Bachman tells investors in a research note. The analyst keeps a Market Perform rating on Accenture following the company's fiscal Q3 results.
IBM (IBM) is scheduled to report results of its fiscal first quarter after the market close on April 24, with a conference call scheduled for 5:00 pm ET. What to watch... To see the rest of the story go to thefly.com. See Story Here